Product
ALG-097558
Aliases
ALG-097558 in solution formulation, ALG-097558 in tablet formulation
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558Status: Recruiting, Estimated PCD: 2024-04-30